Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5653092

C=C(CNCCOC)c1ccc(N)c(C2=CCCCC2)c1.O=C(O)C(F)(F)F

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 11/20 0.63
BDKRB1 P46663 1/20 0.37
PTGER4 P35408 1/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
KDM4E B2RXH2 2/20 0.34
HDAC3 O15379 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CYP2C9 P11712 1/20 0.33
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
KMT2A Q03164 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5653086 0.90 CSF1R (0.62) CSF1RBDKRB1PTGER4KDM4ETDP1
Trifluoroacetic Acid SCHEMBL5651781 0.86 CSF1R (0.59) CSF1RHDAC1HDAC2HDAC3CYP2C9
SCHEMBL5653089 0.84 CSF1R (0.68) CSF1RBDKRB1KDM4ETDP1CYP2C9
Trifluoroacetic Acid SCHEMBL4336424 0.75 CSF1R (0.60) CSF1RHDAC1HDAC2HDAC3RAB9A
SCHEMBL14384985 0.75 CSF1R (0.69) CSF1R
Trifluoroacetic Acid SCHEMBL5651777 0.75 CSF1R (0.57) CSF1RPTGER4CYP2C9
SCHEMBL15436689 0.71 CSF1R (0.68) CSF1R
SCHEMBL14383566 0.70 CSF1R (0.75) CSF1RCYP2C9
Trifluoroacetic Acid SCHEMBL3087736 0.70 CSF1R (0.57) CSF1RCYP2C9
SCHEMBL20817282 0.69 KDM4E (0.48) HDAC1HDAC2KDM4EHDAC3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452996-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2016-09-27 US disclosed
EP-2021329-B1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2016-04-13 EP disclosed
US-20160046602-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2016-02-18 US disclosed
US-9221797-B2 Inhibitors of c-fms kinase JANSSEN PHARMACEUTICA NV (BE) 2015-12-29 US disclosed
US-20140148448-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA NV (BE) 2014-05-29 US disclosed
US-8674100-B2 Inhibitors of C-FMS kinase JANSSEN PHARMACEUTICA, N.V. (BE) 2014-03-18 US disclosed
EP-2687516-A1 Inhibitors of C-FMS Kinase Janssen Pharmaceutica N.V. (BE) 2014-01-22 EP disclosed
US-20070249649-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249649-A1 INHIBITORS OF C-FMS KINASE FES, MUSK, FRK CSF1R 58/4885BDKRB1 1835/4885PTGER4 3225/4885
US-20140148448-A1 INHIBITORS OF C-FMS KINASE FES, MUSK, FRK CSF1R 58/4885BDKRB1 1835/4885PTGER4 3225/4885
US-20160046602-A1 INHIBITORS OF C-FMS KINASE FES, MUSK, FRK CSF1R 58/4885BDKRB1 1835/4885PTGER4 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.